Ellevest, Inc. Axsome Therapeutics, Inc. Transaction History

Ellevest, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$21.74 - $46.75 $1,260 - $2,711	-58 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$23.7 - $41.39 $165 - $289	-7 Reduced 10.77%	58 $2,000
Q3 2021 Oct 19, 2021	BUY	$19.91 - $68.26 $955 - $3,276	48 Added 282.35%	65 $2,000
Q2 2021 Jul 13, 2021	BUY	$50.63 - $73.5 $860 - $1,249	17 New	17 $1,000
Q4 2020 Feb 04, 2021	SELL	$66.31 - $86.52 $66 - $86	-1 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$68.34 - $85.84 $683 - $858	-10 Reduced 90.91%	1 $0
Q2 2020 Jul 06, 2020	BUY	$49.87 - $98.69 $548 - $1,085	11 New	11 $1,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.